Galactic-1:一项随机、双盲、多中心、平行、安慰剂对照的2b期研究,在特发性肺纤维化(IPF)患者中研究TD139的有效性和安全性,TD139是一种吸入式半乳糖凝集素-3抑制剂,通过干粉吸入器给药超过52周

A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher
{"title":"Galactic-1:一项随机、双盲、多中心、平行、安慰剂对照的2b期研究,在特发性肺纤维化(IPF)患者中研究TD139的有效性和安全性,TD139是一种吸入式半乳糖凝集素-3抑制剂,通过干粉吸入器给药超过52周","authors":"A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher","doi":"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":385960,"journal":{"name":"B34. ILD CELLULAR MECHANISMS","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks\",\"authors\":\"A. Mackinnon, S. Khindri, N. Hirani, H. Leffler, U. Nilsson, T. Sethi, A. Pedersen, H. Schambye, C. McClinton, R. Slack, T. Maher\",\"doi\":\"10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":385960,\"journal\":{\"name\":\"B34. ILD CELLULAR MECHANISMS\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"B34. ILD CELLULAR MECHANISMS\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"B34. ILD CELLULAR MECHANISMS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a3065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
A Prospective Randomized, Multicenter Trial Evaluating the Efficacy and Safety of Combined Therapy with Pirfenidone and Inhaled N-Acetylcysteine for Idiopathic Pulmonary Fibrosis Galactic-1: A Randomized, Double-Blind, Multicentre, Parallel, Placebo-Controlled Phase 2b Study in Subjects with Idiopathic Pulmonary Fibrosis (IPF) Investigating the Efficacy and Safety of TD139, an Inhaled Galectin-3 Inhibitor Administered via a Dry Powder Inhaler Over 52 Weeks Upregulation of S100 Calcium Binding Protein A9 Levels in the Lungs of Patients with Idiopathic Pulmonary Fibrosis
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1